Annual Operating Expenses
$270.21 M
+$61.93 M+29.74%
31 March 2024
Summary:
Immunovant annual total operating expenses is currently $270.21 million, with the most recent change of +$61.93 million (+29.74%) on 31 March 2024. During the last 3 years, it has risen by +$162.09 million (+149.92%). IMVT annual operating expenses is now at all-time high.IMVT Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$115.74 M
+$21.46 M+22.76%
30 September 2024
Summary:
Immunovant quarterly total operating expenses is currently $115.74 million, with the most recent change of +$21.46 million (+22.76%) on 30 September 2024. Over the past year, it has increased by +$53.94 million (+87.29%). IMVT quarterly operating expenses is now at all-time high.IMVT Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMVT Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +29.7% | +87.3% |
| 3 y3 years | +149.9% | +207.4% |
| 5 y5 years | - | +10000.0% |
IMVT Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +149.9% | at high | +207.4% |
| 5 y | 5 years | at high | +308.9% | at high | >+9999.0% |
| alltime | all time | at high | +308.9% | at high | >+9999.0% |
Immunovant Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $115.74 M(+22.8%) |
| June 2024 | - | $94.28 M(+16.6%) |
| Mar 2024 | $270.21 M(+29.7%) | $80.88 M(+31.4%) |
| Dec 2023 | - | $61.55 M(-0.4%) |
| Sept 2023 | - | $61.80 M(-6.3%) |
| June 2023 | - | $65.98 M(+2.7%) |
| Mar 2023 | $208.28 M(+33.5%) | $64.26 M(+18.9%) |
| Dec 2022 | - | $54.03 M(+8.9%) |
| Sept 2022 | - | $49.61 M(+22.9%) |
| June 2022 | - | $40.38 M(-14.5%) |
| Mar 2022 | $156.03 M | $47.23 M(+14.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | - | $41.27 M(+9.6%) |
| Sept 2021 | - | $37.65 M(+26.0%) |
| June 2021 | - | $29.89 M(+3.4%) |
| Mar 2021 | $108.12 M(+63.6%) | $28.92 M(-8.6%) |
| Dec 2020 | - | $31.64 M(+50.9%) |
| Sept 2020 | - | $20.97 M(-21.1%) |
| June 2020 | - | $26.59 M(+29.8%) |
| Mar 2020 | $66.08 M | $20.48 M(+85.5%) |
| Dec 2019 | - | $11.04 M(+2530.1%) |
| Sept 2019 | - | $419.80 K(+354.8%) |
| June 2019 | - | $92.30 K(>+9900.0%) |
| Mar 2019 | - | $400.00 |
FAQ
- What is Immunovant annual total operating expenses?
- What is the all time high annual operating expenses for Immunovant?
- What is Immunovant annual operating expenses year-on-year change?
- What is Immunovant quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Immunovant?
- What is Immunovant quarterly operating expenses year-on-year change?
What is Immunovant annual total operating expenses?
The current annual operating expenses of IMVT is $270.21 M
What is the all time high annual operating expenses for Immunovant?
Immunovant all-time high annual total operating expenses is $270.21 M
What is Immunovant annual operating expenses year-on-year change?
Over the past year, IMVT annual total operating expenses has changed by +$61.93 M (+29.74%)
What is Immunovant quarterly total operating expenses?
The current quarterly operating expenses of IMVT is $115.74 M
What is the all time high quarterly operating expenses for Immunovant?
Immunovant all-time high quarterly total operating expenses is $115.74 M
What is Immunovant quarterly operating expenses year-on-year change?
Over the past year, IMVT quarterly total operating expenses has changed by +$53.94 M (+87.29%)